In the field of tumor immunotherapy, researchers have designed some ASOs that silenced immune suppresser gene expression, such as cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and forkhead box P3 (Foxp3), and delayed tumor growth in murine melanoma models [33]. This evidence concerns the gene FOXP3 and neoplasm.